8:00am - 12:30pm WEDNESDAY July 9, 2008
7:00am
Breakfast
OPENING SESSION
8:00am
OPENING REMARKS
Alan Chait (Seattle, WA, USA)
Rodolfo Paoletti (Milan, Italy)
8:15am
OPENING LECTURE
Integrated Biomarkers in Cardiocerebrovascular Diseases
Valentin Fuster (New York, NY, USA)
Scientific Plenary Session 1
HDL AND CARDIOVASCULAR DISEASE
Chair: Alan Chait (Seattle, WA, USA)
Robert Hegele (London, Canada)
9:00am
HDL AS A RISK BIOMARKER AND THERAPY TARGET
B. Greg Brown (Seattle, WA, USA)
9:30am
BEYOND HDL CHOLESTEROL:
APOLIPOPROTEINS AND PARTICLE EVALUATION
Ernst Schaefer (Boston, MA, USA)
10:00am
Coffee Break
10:15am
GENETIC, PROTEOMIC AND LIPIDOMIC APPROACHES TO
DISTURBED HDL METABOLISM
Arnold von Eckardstein (Zurich, Switzerland)
10:45am
HDL PROTEOMICS: A WINDOW TO THE ARTERY WALL?
Jay Heinecke (Seattle, WA, USA)
11:15am
THE ROLES OF THE GPCRs GPR109A AND DP1 IN THE EFFICACY
AND TOLERABILITY OF NICOTINIC ACID
Andrew Taggart (Rahway, NJ, USA)
11:45am
PRESENTATION OF CLINICAL CASES
ASSESSMENT AND MANAGEMENT OF THE PATIENT WITH LOW HDL LEVELS
R. Alan Failor (Seattle, WA, USA)
ACQUIRED FORM OF LOW HDL
John Brunzell (Seattle, WA, USA)
12:30Pm
End of the Session
12:30Pm
Lunch